Advances in Preventive Medicine

Evidence-Based Prevention Interventions for People Who Use Illicit Drugs


Publishing date
21 Dec 2012
Status
Published
Submission deadline
03 Aug 2012

1Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, MD 20857, USA

2Yale AIDS Program, Yale University School of Medicine, New Haven, CT 06510, USA

3President's Emergency Plan for AIDS Relief (PEPFAR), U.S. Embassy, Hanoi, Vietnam


Evidence-Based Prevention Interventions for People Who Use Illicit Drugs

Description

The abuse of illicit drugs and alcohol is global problems with the World Health Organization (WHO) noting that a leading cause of disability is alcohol and drug use disorders (AUDs). Alcohol consumption causes 4% of the total of disability-adjusted life years and 3.2% of deaths. Whereas 2 billion people worldwide consume alcohol, approximately 76.3 million have an AUD. It is estimated that between 149 and 272 million people, or 3.3% to 6.1% of those aged 15-64, used illicit substances in the previous year and that there are between 15 and 39 million problem drug users, globally.

Significant medical problems are associated with alcohol and drug use and abuse. These include psychiatric illness as well as infectious diseases, such as HIV, and noncommunicable diseases.

These medical cooccurring conditions are particularly prevalent in people who use illicit drugs. Estimates for injection drug users (IDUs) are available for 130 countries with approximately 78% of the 13.2 million IDUs living in developing countries. Forty-one countries have reported a high prevalence (>5%) of HIV infection in the IDU population. Globally IDUs now account for at least 10% of all new HIV infections. Recent epidemiological data have shown that generalized HIV epidemics can result from transmission of HIV from IDUs.

Prevention interventions, implemented nationally, regionally, locally, and individually, are fundamental to reduce the medical comorbidities associated with illicit drug use and alcohol abuse. This special issue invites investigators, public health officials, prevention and treatment service providers, and nongovernment organizations to contribute implementation science articles and/or review articles addressing the global burden of disease related to drug and alcohol use and abuse. Potential topics include, but are not limited to, the prevention or treatment of the following:

  • Illicit drug use/abuse
  • Hazardous and harmful alcohol use and abuse
  • Infectious diseases in association with IDU/AUD
    • Tuberculosis
    • Hepatitis
    • Bacterial infections
    • Sexually transmitted diseases
    • Neglected tropical diseases and HIV infection
  • Cardiovascular disease associated with illicit drug use /AUD
  • Cancer in association with illicit drug use /AUD
  • IDU /AUD utilizing gender-based interventions
  • IDU /AUD and commercial sex work or men having sex with men
  • IIDU /AUD and mental health

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/apm/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2013
  • - Article ID 360957
  • - Editorial

Evidence-Based Prevention Interventions for People Who Use Illicit Drugs

Thomas F. Kresina | R. Douglas Bruce | Kevin P. Mulvey
  • Special Issue
  • - Volume 2013
  • - Article ID 690386
  • - Review Article

Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs

Elizabeth Buckingham | Ezra Schrage | Francine Cournos
  • Special Issue
  • - Volume 2013
  • - Article ID 183187
  • - Review Article

An Overview of HIV Prevention Interventions for People Who Inject Drugs in Tanzania

Eric A. Ratliff | Sheryl A. McCurdy | ... | Gad P. Kilonzo
  • Special Issue
  • - Volume 2012
  • - Article ID 308793
  • - Research Article

Evaluation of a Pilot Medication-Assisted Therapy Program in Kazakhstan: Successes, Challenges, and Opportunities for Scaleup

Azizbek A. Boltaev | Anna P. Deryabina | ... | Andrea A. Howard
  • Special Issue
  • - Volume 2012
  • - Article ID 316871
  • - Review Article

HIV Prevention and Rehabilitation Models for Women Who Inject Drugs in Russia and Ukraine

Roman Yorick | Halyna Skipalska | ... | Sara Hodgdon
  • Special Issue
  • - Volume 2012
  • - Article ID 874615
  • - Research Article

Development of Combination HIV Prevention Programs for People Who Inject Drugs through Government and Civil Society Collaboration in the Russian Federation

M. V. Volik | G. A. Karmanova | ... | F. Z. Fattakhov
  • Special Issue
  • - Volume 2012
  • - Article ID 541489
  • - Review Article

Substance Abuse Treatment, HIV/AIDS, and the Continuum of Response for People Who Inject Drugs

Thomas F. Kresina | Robert Lubran | ... | Laura W. Cheever
  • Special Issue
  • - Volume 2012
  • - Article ID 732484
  • - Review Article

Methadone Maintenance Therapy in Vietnam: An Overview and Scaling-Up Plan

Tam T. M. Nguyen | Long T. Nguyen | ... | Kevin P. Mulvey
  • Special Issue
  • - Volume 2012
  • - Article ID 569153
  • - Research Article

Feasibility and Acceptability of Screening and Brief Interventions to Address Alcohol and Other Drug Use among Patients Presenting for Emergency Services in Cape Town, South Africa

Bronwyn Myers | Dan J. Stein | ... | Katherine Sorsdahl
  • Special Issue
  • - Volume 2012
  • - Article ID 796192
  • - Review Article

Sexual Health and Men Who Have Sex with Men in Vietnam: An Integrated Approach to Preventive Health Care

Le Minh Giang | Vu Duc Viet | Bui Thi Minh Hao
Advances in Preventive Medicine
 Journal metrics
Acceptance rate27%
Submission to final decision41 days
Acceptance to publication56 days
CiteScore-
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.